• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Radiol . COVID-19-related intracranial imaging findings: a large single-centre experience

tetano

Editor, Senior Moderator
Clin Radiol


. 2020 Sep 15;S0009-9260(20)30392-5.
doi: 10.1016/j.crad.2020.09.002. Online ahead of print.
COVID-19-related intracranial imaging findings: a large single-centre experience


V Sawlani[SUP] 1 [/SUP], S Scotton[SUP] 2 [/SUP], S Jacob[SUP] 3 [/SUP], K Nader[SUP] 4 [/SUP], J P Jen[SUP] 5 [/SUP], M Patel[SUP] 4 [/SUP], K Gokani[SUP] 2 [/SUP], P Denno[SUP] 2 [/SUP], M Thaller[SUP] 2 [/SUP], C Englezou[SUP] 2 [/SUP], U Janjua[SUP] 5 [/SUP], M Bowen[SUP] 5 [/SUP], C Hoskote[SUP] 6 [/SUP], T Veenith[SUP] 7 [/SUP], G Hassan-Smith[SUP] 3 [/SUP]



Affiliations

Abstract

Aim: To describe the neuroradiological changes in patients with coronavirus disease 2019 (COVID-19).
Materials and methods: A retrospective review was undertaken of 3,403 patients who were confirmed positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and admitted to Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK between 1 March 2020 and 31 May 2020, and who underwent neuroimaging. Abnormal brain imaging was evaluated in detail and various imaging patterns on magnetic resonance imaging MRI were identified.
Results: Of the 3,403 patients with COVID-19, 167 (4.9%) had neurological signs or symptoms warranting neuroimaging. The most common indications were delirium (44/167, 26%), focal neurology (37/167, 22%), and altered consciousness (34/167, 20%). Neuroimaging showed abnormalities in 23% of patients, with MRI being abnormal in 20 patients and computed tomography (CT) in 18 patients. The most consistent neuroradiological finding was microhaemorrhage with a predilection for the splenium of the corpus callosum (12/20, 60%) followed by acute or subacute infarct (5/20, 25%), watershed white matter hyperintensities (4/20, 20%), and susceptibility changes on susceptibility-weighted imaging (SWI) in the superficial veins (3/20, 15%), acute haemorrhagic necrotising encephalopathy (2/20, 10%), large parenchymal haemorrhage (2/20, 10%), subarachnoid haemorrhage (1/20, 5%), hypoxic-ischaemic changes (1/20, 5%), and acute disseminated encephalomyelitis (ADEM)-like changes (1/20, 5%).
Conclusion: Various imaging patterns on MRI were observed including acute haemorrhagic necrotising encephalopathy, white matter hyperintensities, hypoxic-ischaemic changes, ADEM-like changes, and stroke. Microhaemorrhages were the most common findings. Prolonged hypoxaemia, consumption coagulopathy, and endothelial disruption are the likely pathological drivers and reflect disease severity in this patient cohort.
 
Back
Top Bottom